Skip to main content
. Author manuscript; available in PMC: 2022 Dec 15.
Published in final edited form as: Cancer. 2021 Aug 5;127(24):4574–4584. doi: 10.1002/cncr.33855

Figure 1:

Figure 1:

Proportion AYA among adults with cancer over time by five-year increments. Over the entire 25 year period, 8.4% of enrollments to SWOG treatment trials were AYA patients, compared to 3.8% for similar cancers in the U.S. cancer population.